Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SB17170 Phase 1 Clinical Trial in Solid Tumors — Stella

Home/Solid Tumor/SB17170 Phase 1 Clinical Trial in Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Solid Tumor trials

SB17170 Phase 1 Clinical Trial in Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

South Korea

Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Key details

Phase

Early testing

Sponsor

SPARK Biopharma

Enrollment target

~50 participants

Started

October 2022

Primary completion

June 2027

Age range

19 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.